Literature DB >> 22549772

Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases.

Duy T Tran1, Jae-Min Lim, Mian Liu, Stephanie H Stalnaker, Lance Wells, Kelly G Ten Hagen, David Live.   

Abstract

O-Linked glycosylation is a functionally and structurally diverse type of protein modification present in many tissues and across many species. α-Dystroglycan (α-DG), a protein linked to the extracellular matrix, whose glycosylation status is associated with human muscular dystrophies, displays two predominant types of O-glycosylation, O-linked mannose (O-Man) and O-linked N-acetylgalactosamine (O-GalNAc), in its highly conserved mucin-like domain. The O-Man is installed by an enzyme complex present in the endoplasmic reticulum. O-GalNAc modifications are initiated subsequently in the Golgi apparatus by the UDP-GalNAc polypeptide N-acetylgalactosaminyltransferase (ppGalNAc-T) enzymes. How the presence and position of O-Man influences the action of the ppGalNAc-Ts on α-DG and the distribution of the two forms of glycosylation in this domain is not known. Here, we investigated the interplay between O-Man and the addition of O-GalNAc by examining the activity of the ppGalNAc-Ts on peptides and O-Man-containing glycopeptides mimicking those found in native α-DG. These synthetic glycopeptides emulate intermediate structures, not otherwise readily available from natural sources. Through enzymatic and mass spectrometric methods, we demonstrate that the presence and specific location of O-Man can impact either the regional exclusion or the site of O-GalNAc addition on α-DG, elucidating the factors contributing to the glycosylation patterns observed in vivo. These results provide evidence that one form of glycosylation can influence another form of glycosylation in α-DG and suggest that in the absence of proper O-mannosylation, as is associated with certain forms of muscular dystrophy, aberrant O-GalNAc modifications may occur and could play a role in disease presentation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22549772      PMCID: PMC3375520          DOI: 10.1074/jbc.M112.370387

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

Review 1.  Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function.

Authors:  Daniel E Michele; Kevin P Campbell
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

2.  Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.

Authors:  Yuji Hara; Motoi Kanagawa; Stefan Kunz; Takako Yoshida-Moriguchi; Jakob S Satz; Yvonne M Kobayashi; Zihan Zhu; Steven J Burden; Michael B A Oldstone; Kevin P Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

3.  Distinct orders of GalNAc incorporation into a peptide with consecutive threonines.

Authors:  K Kato; H Takeuchi; N Miyahara; A Kanoh; H Hassan; H Clausen; T Irimura
Journal:  Biochem Biophys Res Commun       Date:  2001-09-14       Impact factor: 3.575

4.  Glycomic analyses of mouse models of congenital muscular dystrophy.

Authors:  Stephanie H Stalnaker; Kazuhiro Aoki; Jae-Min Lim; Mindy Porterfield; Mian Liu; Jakob S Satz; Sean Buskirk; Yufang Xiong; Peng Zhang; Kevin P Campbell; Huaiyu Hu; David Live; Michael Tiemeyer; Lance Wells
Journal:  J Biol Chem       Date:  2011-04-01       Impact factor: 5.157

5.  Functional conservation of subfamilies of putative UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferases in Drosophila, Caenorhabditis elegans, and mammals. One subfamily composed of l(2)35Aa is essential in Drosophila.

Authors:  Tilo Schwientek; Eric P Bennett; Carlos Flores; John Thacker; Martin Hollmann; Celso A Reis; Jane Behrens; Ulla Mandel; Birgit Keck; Mireille A Schäfer; Kim Haselmann; Roman Zubarev; Peter Roepstorff; Joy M Burchell; Joyce Taylor-Papadimitriou; Michael A Hollingsworth; Henrik Clausen
Journal:  J Biol Chem       Date:  2002-03-29       Impact factor: 5.157

6.  High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis.

Authors:  W Chai; C T Yuen; H Kogelberg; R A Carruthers; R U Margolis; T Feizi; A M Lawson
Journal:  Eur J Biochem       Date:  1999-08

7.  Initiation of mammalian O-mannosylation in vivo is independent of a consensus sequence and controlled by peptide regions within and upstream of the alpha-dystroglycan mucin domain.

Authors:  Isabelle Breloy; Tilo Schwientek; Barbara Gries; Hanieh Razawi; Marcus Macht; Christian Albers; Franz-Georg Hanisch
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

8.  Role of peptide sequence and neighboring residue glycosylation on the substrate specificity of the uridine 5'-diphosphate-alpha-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyl transferases T1 and T2: kinetic modeling of the porcine and canine submaxillary gland mucin tandem repeats.

Authors:  Thomas A Gerken; Chhavy Tep; Jason Rarick
Journal:  Biochemistry       Date:  2004-08-03       Impact factor: 3.162

9.  Enrichment and site mapping of O-linked N-acetylglucosamine by a combination of chemical/enzymatic tagging, photochemical cleavage, and electron transfer dissociation mass spectrometry.

Authors:  Zihao Wang; Namrata D Udeshi; Meaghan O'Malley; Jeffrey Shabanowitz; Donald F Hunt; Gerald W Hart
Journal:  Mol Cell Proteomics       Date:  2009-08-19       Impact factor: 5.911

Review 10.  Dystroglycan glycosylation and muscular dystrophy.

Authors:  Christopher J Moore; Jane E Hewitt
Journal:  Glycoconj J       Date:  2008-09-05       Impact factor: 2.916

View more
  10 in total

Review 1.  The o-mannosylation pathway: glycosyltransferases and proteins implicated in congenital muscular dystrophy.

Authors:  Lance Wells
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

Review 2.  Dissecting the molecular basis of the role of the O-mannosylation pathway in disease: α-dystroglycan and forms of muscular dystrophy.

Authors:  David Live; Lance Wells; Geert-Jan Boons
Journal:  Chembiochem       Date:  2013-11-07       Impact factor: 3.164

3.  Mammalian O-mannosylation of cadherins and plexins is independent of protein O-mannosyltransferases 1 and 2.

Authors:  Ida Signe Bohse Larsen; Yoshiki Narimatsu; Hiren Jitendra Joshi; Zhang Yang; Oliver J Harrison; Julia Brasch; Lawrence Shapiro; Barry Honig; Sergey Y Vakhrushev; Henrik Clausen; Adnan Halim
Journal:  J Biol Chem       Date:  2017-05-16       Impact factor: 5.157

4.  Protein O-mannosylation in metazoan organisms.

Authors:  Vladislav M Panin; Lance Wells
Journal:  Curr Protoc Protein Sci       Date:  2014-02-03

5.  N-glycosylation requirements in neuromuscular synaptogenesis.

Authors:  William Parkinson; Mary Lynn Dear; Emma Rushton; Kendal Broadie
Journal:  Development       Date:  2013-11-13       Impact factor: 6.868

6.  Contrasting the conformational effects of α-O-GalNAc and α-O-Man glycan protein modifications and their impact on the mucin-like region of alpha-dystroglycan.

Authors:  Andrew Borgert; B Lachele Foley; David Live
Journal:  Glycobiology       Date:  2021-06-03       Impact factor: 4.313

7.  The Structure of the T190M Mutant of Murine α-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy.

Authors:  Manuela Bozzi; Alberto Cassetta; Sonia Covaceuszach; Maria Giulia Bigotti; Saskia Bannister; Wolfgang Hübner; Francesca Sciandra; Doriano Lamba; Andrea Brancaccio
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

Review 8.  Mammalian O-mannosylation pathway: glycan structures, enzymes, and protein substrates.

Authors:  Jeremy L Praissman; Lance Wells
Journal:  Biochemistry       Date:  2014-05-07       Impact factor: 3.162

9.  The GalNAc-T Activation Pathway (GALA) is not a general mechanism for regulating mucin-type O-glycosylation.

Authors:  Gaetan G Herbomel; Raul E Rojas; Duy T Tran; Monica Ajinkya; Lauren Beck; Lawrence A Tabak
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

10.  Probing the stability of the "naked" mucin-like domain of human α-dystroglycan.

Authors:  Manuela Bozzi; Enrico Di Stasio; Giovanni Luca Scaglione; Claudia Desiderio; Claudia Martelli; Bruno Giardina; Francesca Sciandra; Andrea Brancaccio
Journal:  BMC Biochem       Date:  2013-07-01       Impact factor: 4.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.